Application of N-acetly glucosamine in the preparation of medicine for treating local injury and full body syndrome due to virus or bacterial infestation

An acetamido, bacterial infection technology, applied in antibacterial, anti-infective, antiviral and other directions, to achieve good prognosis, rapid action, and the effect of relieving local damage

Inactive Publication Date: 2004-10-06
ARMY MEDICAL UNIV +2
View PDF0 Cites 14 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there are no effective measures and drugs to control viral infection, and only some supportive treatments are taken

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of N-acetly glucosamine in the preparation of medicine for treating local injury and full body syndrome due to virus or bacterial infestation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] Embodiment 1. The wave-promoting test of the compound of formula (I)

[0019] 1. Test materials and methods:

[0020] 1.1 Sample: pure compound of formula (I).

[0021] 1.2 Test material:

[0022] Strains: Proteus mirabilis should meet the following biochemical reaction characteristics: power (+), urease (+), lactose (-), glucose (+), H 2 S (-), phenylalanine deaminase (+).

[0023] Medium: modified LB medium (composition: 1% tryptone, 0.5% yeast extract, 1% sodium chloride, 0.1% glucose, 0.002% TTC, pH7.2-7.4).

[0024] 1.3 Test method:

[0025] Control sample: plant Proteus mirabilis in the center of the LB plate and culture at 37°C for 9 hours;

[0026] Test sample: Add the compound of formula (I) at a final concentration of 0.5% to the LB plate, plant Proteus mirabilis in the same way, and culture at 37° C. for 9 hours.

[0027] 2. Test results and evaluation:

[0028] In the control sample, there are concentric rings that continuously expand outwards at inte...

Embodiment 2

[0030] The toxicological test of embodiment 2. formula (I) compound

[0031] Carry out the toxicology test of formula (I) compound, comprise:

[0032] 1. Acute toxicology test: including oral, intravenous injection and maximum dose administration test;

[0033] 2. Ames test;

[0034] 3. Mouse bone marrow cell micronucleus test;

[0035] 4. Mouse sperm teratogenic test;

[0036] 5. Chromosomal aberration test of mouse testis;

[0037] 6. Chronic lethal test;

[0038] 7. Subchronic toxicity (90-day feeding) test;

[0039] 8. Traditional teratogenicity test;

[0040] Test conclusion shows: when formula (I) compound acute toxicity test dose exceeds 2g / kg, acute poisoning reaction does not yet occur; In long-term toxicity test, the highest dose has reached 1g / kg, through four weeks test observation, no toxic reaction occurs; In the reproduction test, mice were fed from a conventional dose of 7 mg / kg, and after three passages, it was proved that the compound of formula (I) ha...

Embodiment 3

[0041] Example 3. Cytological test for regulation of microheterogeneic changes

[0042] The conventional incomplete 1640 medium was used for cell culture, and B16 tumor cells (purchased from Shanghai Institute of Cell Biology Tumor Cell Bank) were inoculated. In the continuous culture for more than 48 hours, under the condition that the waste of cell metabolism affects the growth environment, the changes of the micro-heterogeneity of the cells and the control effect of N-acetylglucosamine on them were observed. After adding N-acetylglucosamine with a final concentration of 1g / 100ml in the culture medium, the number of cells increased steadily with the prolongation of culture time during the growth process. Control test cells could not proliferate in the same medium and under the same culture conditions in the absence of N-acetylglucosamine. The test shows that under the condition of the compound of formula (1), the cells can adjust the micro-heterologous changes of the cells ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

An application of N-acetylaminoglucose in preparing the medicines for treating the local injury and general sympton caused by virus or bacterium infection is disclosed. It has high curative effect up to 90%.

Description

technical field [0001] The invention relates to the application of N-acetylglucosamine or pharmaceutically acceptable salt derivatives thereof in the preparation of medicines for treating local damage and systemic symptoms caused by bacterial and / or viral infections. Background technique [0002] Symptoms of systemic poisoning caused by bacterial and / or viral infection, including endotoxemia and local damage caused by exotoxins, such as fever, headache, dizziness, delirium, nausea, vomiting, and general malaise. At present, there are mainly two methods for the treatment of systemic poisoning symptoms caused by bacterial infection: 1. antibacterial treatment; 2. supportive therapy. [0003] Viral infections are mainly seen in coxsackie virus, ECHO virus, orthomyxovirus, paramyxovirus, adenovirus, coronavirus, reovirus, respiratory syncytial virus, rhinovirus, hepatitis A, B, C virus and Japanese encephalitis Viruses, causing fever and other systemic pois...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/7008A61P31/00A61P39/00
CPCA61K31/7008A61P29/00A61P31/00A61P31/04A61P31/12A61P39/00
Inventor 徐启旺刘俊康袁泽涛
Owner ARMY MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap